PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
144.23%
Some net income increase while CSIQ is negative at -44.48%. John Neff would see a short-term edge over the struggling competitor.
3.55%
D&A growth of 3.55% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
No Data
No Data available this quarter, please select a different quarter.
28.25%
SBC growth of 28.25% while CSIQ is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
65.78%
Working capital change of 65.78% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
100.00%
AR growth of 100.00% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
69.80%
Inventory growth of 69.80% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-100.00%
Negative yoy AP while CSIQ is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
66.63%
Growth of 66.63% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-300.00%
Negative yoy while CSIQ is 44.48%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
143.24%
CFO growth of 143.24% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a modest edge that could widen if cost discipline remains strong.
12.80%
CapEx growth of 12.80% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost burden that must yield returns in future revenue or margins.
100.00%
Acquisition growth of 100.00% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
69.96%
Purchases growth of 69.96% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-55.04%
We reduce yoy sales while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
171.29%
Growth of 171.29% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
117.47%
We expand invests by 117.47% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a moderate outflow that must be justified by returns vs. competitor’s stable approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
74.21%
Buyback growth of 74.21% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.